Validation of a new questionnaire with generic and disease-specific qualities: The McGill COPD quality of life questionnaire

Canadian Respiratory Journal

Volumn 19, Issue 6, 2012, Pages 367-372

  Pakhale, Smita ^a   Wood Dauphinee, Sharon ^b,c   Spahija, Adriana ^c   Collet, Jean Paul ^d   Maltais, François ^e   Bernard, Sarah ^e   Baltzan, Marc ^c   Rouleau, Michel ^f   Bourbeau, Jean ^b,g  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e LAVAL UNIVERSITY   (Canada)

^f CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^g MCGILL UNIVERSITY   (Canada)

Author keywords

COPD; Disease specific; Generic; Health related quality of life; hybrid; Psychometric property; Quality of life

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CRONBACH ALPHA COEFFICIENT; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; MCGILL COPD QUALITY OF LIFE QUESTIONNAIRE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY REHABILITATION; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM 36; SMOKING; TEST RETEST RELIABILITY; VALIDATION STUDY; VALIDITY;

EID: 84870984886     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2012/914138     Document Type: Article

References (46)

1. Buist AS, Vollmer WM, McBurnie MA. Worldwide burden of COPD in high- and low-income countries. Part I. The Burden of Obstructive Lung Disease (BOLD) Initiative. Int J Tuberc Lung Dis 2008;12:703-8. (Pubitemid 351976696)
2. Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005;294:1255-9. (Pubitemid 41352114)
3. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD Executive Summary. Am J Respir Crit Care Med 2007;176:532-55. (Pubitemid 47403272)
4. Weiss ST, DeMeo DL, Postma DS. COPD: Problems in diagnosis and measurement. Eur Respir J 2003;21(41Suppl):4S-12.
5. Engstrom CP, Persson LO, Larsson S, Sullivan M. Health-related quality of life in COPD: Why both disease-specific and generic measures should be used. Eur Respir J 2001;18:69-76. (Pubitemid 32717433)
6. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:785-90.
7. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Int Med 1993;118:622-9. (Pubitemid 23102698)
8. Mokkink LB, Terwee CB, Knol DL, et al. Protocol of the COSMIN study: COnsensus-based Standards for the selection of health Measurement INstruments. BMC Med Res Methodol 2006;6:2.
9. Mahler DA. How Should health-related quality of life be assessed in patients with COPD? Chest 2000;117:54S-557.
10. Barr JT, Schumacher GE, Freeman S, LeMoine M, Bakst AW, Jones PW. American translation, modification, and validation of the St George's Respiratory Questionnaire. Clin Ther 2000;22:1121-45.
11. Bourbeau J, Maltais F, Rouleau M, Guimont C. French-Canadian version of the Chronic Respiratory and St George's Respiratory questionnaires: An assessment of their psychometric properties in patients with chronic obstructive pulmonary disease. Can Respir J 2004;11:480-6. (Pubitemid 39549459)
12. Green RH, Singh SJ, Williams J, Morgan MDL. A randomised controlled trial of four weeks versus seven weeks of pulmonary rehabilitation in chronic obstructive pulmonary disease. Thorax 2001;56:143-5.
13. van den Boom G, Rutten-van Mölken MP, Molema J, Tirimanna PR, van Weel C, van Schayck CP. The cost effectiveness of early treatment with fluticasone propionate 250 ++ g twice a day in subjects with obstructive airway disease. Am J Respir Crit Care Med 2001;164:2057-66.
14. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987;42:773-8. (Pubitemid 17142007)
15. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145:1321-7.
16. Lacasse Y, Wong E, Guyatt GH, Goldstein RS. Health status measurement instruments in chronic obstructive pulmonary disease. Can Respir J 1997;4:152-64. (Pubitemid 27344504)
17. Williams JEA, Singh SJ, Sewell L, Guyatt GH, Morgan MDL. Development of a self-reported Chronic Respiratory Questionnaire (CRQ-SR). Thorax 2001;56:954-9. (Pubitemid 33097191)
18. Schunemann HJ, Puhan M, Goldstein R, Jaeschke R, Guyatt GH. Measurement properties and interpretability of the Chronic respiratory disease questionnaire (CRQ). COPD 2005;2:81-9. (Pubitemid 40778678)
19. Xu W, Collet JP, Shapiro S, Lin Y, Yang T, Wang C, Bourbeau J. Validation and clinical interpretation of the St George's Respiratory Questionnaire among COPD patients, China. Int J Tuberc Lung Dis 2009;13:181-9.
20. Preston CC, Colman AM. Optimal number of response categories in rating scales: Reliability, validity, discriminating power, and respondent preferences. Acta Psychologica 2000;104:1-15.
21. Miller GA. The magical number seven, plus or minus two: Some limits on our capacity for processing information. Psycho Rev 1956;63:81-97.
22. Jones RR. Differences in response consistency and subjects' preferences for three personality inventory response formats. In: Proceedings of the 76th Annual Convention of the American Psychological Association, Washington DC;1968:247-8.
23. Ware JE Jr, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care 1992;30:473-83.
24. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-63.
25. Pakhale S, Wood-Dauphinee S, Spahija J, et al. Combining both generic and disease-specific properties: Development of the McGill COPD quality of life questionnaire. COPD 2011;8:255-63.
26. Nici L, Donner C, Wouters E, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006;173:1390-413. (Pubitemid 43900715)
27. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-38. (Pubitemid 41079078)
28. Wanger J, Clausen JL, Coates A, e al. Standardisation of the measurement of lung volumes. Eur Respir J 2005;26:511-22.
29. Quanjer Ph H, Tammeling GJ, Cotes JE. Lung volumes and forced ventilatory flows. Eur Respir J 1993;6(Suppl 16):5-40. (Pubitemid 23116782)
30. Guyatt GH, Pugsley SO, Sullivan MJ, et al. Effect of encouragement on walking test performance. Thorax 1984;39:818-22. (Pubitemid 14022730)
31. ATS Statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-7.
32. Ware J, Kosinski M. SF-36 Physical and Mental Health Summary Scales: A Manual for Users of Version 1, 2nd edn. Lincoln: Quality Metric; 2001.
33. Cheung YB, Daniel R, Ng GY. Response and non-response to a quality-of-life question on sexual life: A case study of the simple mean imputation method. Qual Life Res 2006;15:1493-501. (Pubitemid 44736782)
34. Cronbach LJ. Coefficient and the internal structure of tests. Psychometrika 1951;16:297-334.
35. Shrout P FJ. Shrout P, Fleiss J. Intraclass correlations: Uses in assessing rater reliability. Psychol Bull 1979;36:420-8. Psychol Bull 1979;36:420-8.
36. Norman G, Wyrwich K, Patrick D. The mathematical relationship among different forms of responsiveness coefficients. Qual Life Res 2007;16:815-22. (Pubitemid 46650889)
37. Bourbeau J, Maltais F, Rouleau M, Guimont C. French-Canadian version of the Chronic Respiratory and St George's Respiratory questionnaires: An assessment of their psychometric properties in patients with chronic obstructive pulmonary disease. Can Respir J 2004;11:480-6. (Pubitemid 39549459)
38. R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. Vienna, 2008.
39. Barr JT, Schumacher GE, Freeman S, LeMoine M, Bakst AW, Jones PW. American translation, modification, and validation of the St George's Respiratory Questionnaire. Clin Thera 2000;22:1121-45.
40. Prieto L, Alonso J, Ferrer M, Anto JM. Are results of the SF-36 health survey and the nottingham health profile similar?: A comparison in COPD patients. J Clin Epidemiol 1997;50:463-73. (Pubitemid 27223276)
41. Nunnally JC. Psychometric Theory. New York: McGraw-Hill, 1994.
42. Cohen J. Statistical Power Analysis for the Behavioral Sciences, 2nd edn. Hilsdale: Lawrence Erlbaum, 1988.
43. Verrill D, Barton C, Beasley W, Lippard WM. The effects of short-term and long-term pulmonary rehabilitation on functional capacity, perceived dyspnea, and quality of life. Chest 2005;128:673-83. (Pubitemid 41140495)
44. Samsa G, Edelman D, Rothman ML, Williams GR, Lipscomb J, Matchar D. Determining clinically important differences in health status measures: A general approach with illustration to the Health utilities Index Mark II. Pharmacoeconomics 1999;15:141-55. (Pubitemid 29093257)
45. Griffiths TL, Burr ML, Campbell IA, et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: A randomised controlled trial. Lancet 2000;355:362-8.
46. Streiner DL, Norman GR. Health Measurment Scales. A Practical Guide to Their Development and Use, 3rd edn. New York: Oxford University Press, 2002.